StocksFin Logo
Omeros Corporation country of incorporation
|
|
Dr. Gregory Demopulos
|
213 employees
NASDAQ | Healthcare | Biotechnology
Cellectis S.A. country of incorporation
|
|
Dr. Andr Choulika
|
294 employees
NASDAQ | Healthcare | Biotechnology
Q322 reported Nov 9, 2022 Reporting Period
$0 -100% vs. Q321 Revenues Q322
0% -100% vs. Q321 Gross Profit Margin
0% 100% vs. Q321 Net Profit Margin
-61.2M ! -158.7% vs. Q321 Free Cash Flow Q322
$0.6 266.7% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Q322 reported Sep 30, 2022 Reporting Period
$217k -97.4% vs. Q321 Revenues Q322
-69.12% -537% vs. Q321 Gross Profit Margin
-1000% ! -122.2% vs. Q321 Net Profit Margin
-24.87M ! -105.1% vs. Q321 Free Cash Flow Q322
$-0.63 ! 23.2% vs. Q321 EPS Q322
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q322
Ratios
As of
Sep 30, 2022
Dec 31, 2021
Quick Ratio
5.94
4.4
Current Ratio
7.3
4.57
Cash Ratio
3.68
3.76
Price to Book
-4.27
1.15
Price to Sales
0
4.45
Price to Earnings
1.32
-2.23